Hls Therapeutics (TSE:HLS) has released an update.
HLS Therapeutics Inc. is set to release its first-quarter financial results for fiscal year 2024 on May 9, with a conference call scheduled for that morning. Investors and interested parties can join the call via webcast or traditional phone lines, with a taped replay available for two weeks following the event. HLS specializes in acquiring and commercializing pharmaceuticals for psychiatric and cardiovascular diseases in North American markets.
For further insights into TSE:HLS stock, check out TipRanks’ Stock Analysis page.
